Suggested Age: 12 Years and Up
Health Facts: Contains Phenylephrine HCI, Contains Expectorant, Contains Dextromethorphan HBr, Contains Acetaminophen, Contains Pain Reliever, Contains Guaifenesin
Active Ingredient Strength Value: 325 Milligrams
Product Warning: Consult a doctor if you are pregnant or nursing, Contains Acetaminophen
Product Form: Caplet
Primary Active Ingredient: Acetaminophen
Package Quantity: 20
Net weight: .07 Pounds
Features: Daytime and Nighttime Use, Daytime Use, Multi-Symptom
•MAXIMUM STRENGTH RELIEF: Maximum Strength Mucinex Sinus-Max Pressure, Pain & Cough helps relieve cough, stuffy nose, chest & nasal congestion, headache and minor aches and pains
•#1 TRUSTED COLD AND COUGH BRAND: #1 Cold and Cough brand doctors trust for themselves and their families
•PAIN RELIEVER: Contains Acetaminophen which relieves minor aches, pains and headache
•COUGH SUPPRESSANT: Contains Dextromethorphan HBr that helps relieve cough
•EXPECTORANT: Contains Guaifenesin that thins and loosens mucus; relieves chest congestion
•NASAL DECONGESTANT: Contains Phenylephrine HCl that provides relief for nasal congestion,
sinus congestion and pressure
•USAGE: Use as directed; For ages 12+ years
Maximum Strength Mucinex Sinus-Max Pressure, Pain & Cough is an OTC medicine for relief of your Nasal and Chest Congestion symptoms. Maximum Strength Mucinex Sinus-Max Pressure, Pain & Cough helps relieve cough, stuffy nose, chest & nasal congestion, headache and minor aches and pains. Mucinex is the #1 Cold and Cough brand doctors trust for themselves and their families*. This product contains 20 Caplets. It can be used by Adults and Children 12 years of age and over.
SYMPTOMS RELIEVED: Maximum Strength Mucinex Sinus-Max Pressure, Pain & Cough helps relieve cough, stuffy nose, chest & nasal congestion, headache and minor aches and pains
ACTIVE INGREDIENTS: Contains Acetaminophen - pain reliever; Dextromethorphan HBr - cough suppressant; Guaifenesin - expectorant; Phenylephrine HCI - nasal decongestant
Take only as Directed
*IQVIA using ProVoice Survey, August 2020